Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases

Cellular and Molecular Life Sciences

Volumn 68, Issue 6, 2011, Pages 931-949

  Bencherif, Merouane ^a   Lippiello, Patrick M ^a   Lucas, Rudolf ^b   Marrero, Mario B ^b  

^a TARGACEPT INC   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Acetylcholine; Alpha7; Diabetes; Inflammation; Nicotinic

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; 3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; 4 CHLORO N (3 QUINUCLIDINYL)BENZAMIDE; 4 DIMETHYLAMINOBENZALDEHYDE; ACETYLCHOLINE; ALPHA BUNGAROTOXIN; ANABASEINE; BUNGAROTOXIN RECEPTOR; CAP 55; CHLORISONDAMINE; COTININE; MECAMYLAMINE; METHYLLYCACONITINE; NICOTINE; NICOTINIC AGENT; PHA 568487; SPIRO[1 AZABICYCLO[2.2.2]OCTANE 3,2' THIAZOLIDINE] 2' ONE; TC 7020; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ASTHMA; ATHEROSCLEROSIS; BACTERIAL INFECTION; CHOLINERGIC ACTIVITY; CHOLINERGIC SYSTEM; CYSTIC FIBROSIS; DRUG STRUCTURE; DRUG TARGETING; ENTERITIS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY DISEASE; MACROPHAGE; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PSORIASIS; PSORIATIC ARTHRITIS; REVIEW; SEPSIS; ULCERATIVE COLITIS;

ARTHRITIS; ASTHMA; COLITIS, ULCERATIVE; CYSTIC FIBROSIS; CYTOKINES; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NICOTINIC AGONISTS; PARKINSON DISEASE; PSORIASIS; RECEPTORS, NICOTINIC; SEPSIS;

EID: 79953703686     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-010-0525-1     Document Type: Review

References (157)

1. R Haverslag G Pasterkamp IE Hoefer 2008 Targeting adhesion molecules in cardiovascular disorders Cardiovasc Hematol Disord Drug Targets 8 252 260 1:CAS:528:DC%2BD1cXhsVKitb7E 19075635
2. DD Chaplin 2010 Overview of the immune response J Allergy Clin Immunol 125 S3 S23 20176265
3. M Loiarro V Ruggiero C Sette 2010 Targeting TLR/IL-1R signalling in human diseases Mediators Inflamm 2010 674363 20396389
4. SM Opal 2010 Endotoxins and other sepsis triggers Contrib Nephrol 167 14 24 1:CAS:528:DC%2BC3cXhtlCrtLrN 20519895
5. SP Commins L Borish JW Steinke 2010 Immunologic messenger molecules: cytokines, interferons, and chemokines J Allergy Clin Immunol 125 S53 S72 19932918
6. AH Sprague RA Khalil 2009 Inflammatory cytokines in vascular dysfunction and vascular disease Biochem Pharmacol 78 539 552 1:CAS:528:DC%2BD1MXpt1Kls7w%3D 19413999
7. L Duvnjak M Duvnjak 2009 The metabolic syndrome-an ongoing story J Physiol Pharmacol 60 Suppl 7 19 24 20388942
8. JM Olefsky CK Glass 2010 Macrophages, inflammation, and insulin resistance Annu Rev Physiol 72 219 246 1:CAS:528:DC%2BC3cXktFKkt70%3D 20148674
9. T Tzanavari P Giannogonas KP Karalis 2010 TNF-alpha and obesity Curr Dir Autoimmun 11 145 156 1:CAS:528:DC%2BC3cXnvFWmsLk%3D 20173393
10. P Jiao Q Chen S Shah J Du B Tao I Tzameli W Yan H Xu 2009 Obesity-related upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor-kappaB and c-Jun NH2-terminal kinase pathways Diabetes 58 104 115 1:CAS:528:DC%2BD1MXptVChuw%3D%3D 18835938
11. K Rabe M Lehrke KG Parhofer UC Broedl 2008 Adipokines and insulin resistance Mol Med 14 741 751 1:CAS:528:DC%2BD1cXhsVOgu7jN 19009016
12. M Filkova M Haluzik S Gay L Senolt 2009 The role of resistin as a regulator of inflammation: implications for various human pathologies Clin Immunol 133 157 170 1:CAS:528:DC%2BD1MXht1GnsrnM 19740705
13. EJ Folco VZ Rocha M Lopez-Ilasaca P Libby 2009 Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10 J Biol Chem 284 25569 25575 1:CAS:528:DC%2BD1MXhtFWhsbvF 19617629
14. S Devaraj U Singh I Jialal 2009 Human C-reactive protein and the metabolic syndrome Curr Opin Lipidol 20 182 189 1:CAS:528:DC%2BD1MXls1Gltbc%3D 19369869
15. D Galasko TJ Montine 2010 Biomarkers of oxidative damage and inflammation in Alzheimer's disease Biomark Med 4 27 36 1:CAS:528:DC%2BC3cXhsFCnu7s%3D 20383271
16. S Mandrekar-Colucci GE Landreth 2010 Microglia and inflammation in Alzheimer's disease CNS Neurol Disord Drug Targets 9 156 167 1:CAS:528:DC%2BC3cXlsFKnurY%3D 20205644
17. ZS Tan S Seshadri 2010 Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander? Alzheimers Res Ther 2 6 20388190
18. LE Rojo JA Fernandez AA Maccioni JM Jimenez RB Maccioni 2008 Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease Arch Med Res 39 1 16 1:CAS:528:DC%2BD2sXhsVSmtbvM 18067990 (Pubitemid 350192021)
19. FM Brennan IB McInnes 2008 Evidence that cytokines play a role in rheumatoid arthritis J Clin Invest 118 3537 3545 1:CAS:528:DC%2BD1cXhtlGltLrJ 18982160
20. JA Jazayeri GJ Carroll AB Vernallis 2010 Interleukin-6 subfamily cytokines and rheumatoid arthritis: role of antagonists Int Immunopharmacol 10 1 8 1:CAS:528:DC%2BC3cXjsl2jug%3D%3D 19804846
21. E Toussirot D Wendling 2007 The use of TNF-alpha blocking agents in rheumatoid arthritis: an update Expert Opin Pharmacother 8 2089 2107 1:CAS:528:DC%2BD2sXpsFSgtro%3D 17714062 (Pubitemid 47505587)
22. E Lubberts 2010 Th17 cytokines and arthritis Semin Immunopathol 32 43 53 1:CAS:528:DC%2BC3cXjtFyisro%3D 20127485
23. S Lee M Ballow 2010 Monoclonal antibodies and fusion proteins and their complications: targeting B cells in autoimmune diseases J Allergy Clin Immunol 125 814 820 1:CAS:528:DC%2BC3cXktlGju74%3D 20371395
24. PA Nigrovic DM Lee 2007 Synovial mast cells: role in acute and chronic arthritis Immunol Rev 217 19 37 1:CAS:528:DC%2BD2sXnt1Gmtbg%3D 17498049 (Pubitemid 46718141)
25. PA Nigrovic BA Binstadt PA Monach A Johnsen M Gurish Y Iwakura C Benoist D Mathis DM Lee 2007 Mast cells contribute to initiation of autoantibody- mediated arthritis via IL-1 Proc Natl Acad Sci USA 104 2325 2330 1:CAS:528:DC%2BD2sXisVWrtrg%3D 17277081 (Pubitemid 46391396)
26. B Bartok GS Firestein 2010 Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis Immunol Rev 233 233 255 1:CAS:528: DC%2BC3cXjslaqsr4%3D 20193003
27. H Uysal KS Nandakumar C Kessel S Haag S Carlsen H Burkhardt R Holmdahl 2010 Antibodies to citrullinated proteins: molecular interactions and arthritogenicity Immunol Rev 233 9 33 1:CAS:528:DC%2BC3cXjslartbk%3D 20192990
28. B Dua RM Watson GM Gauvreau PM O'Byrne 2010 Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma J Allergy Clin Immunol 126 133 139 1:CAS:528:DC%2BC3cXosVGrtr8%3D 20538329
29. PG Holt DH Strickland 2010 Interactions between innate and adaptive immunity in asthma pathogenesis: new perspectives from studies on acute exacerbations J Allergy Clin Immunol 125 963 972 1:CAS:528:DC%2BC3cXlvVWls7g%3D 20394979
30. FD Finkelman SP Hogan GK Hershey ME Rothenberg M Wills-Karp 2010 Importance of cytokines in murine allergic airway disease and human asthma J Immunol 184 1663 1674 1:CAS:528:DC%2BC3cXhsVGltLw%3D 20130218
31. PJ Barnes 2007 New molecular targets for the treatment of neutrophilic diseases J Allergy Clin Immunol 119 1055 1062 1:CAS:528:DC%2BD2sXkslektLw%3D 17353033 (Pubitemid 46654167)
32. AJ Tavakkol HR Farid FS Hosseini F Heydarian MH Boskabady R Khoshnavaz A Razavi KE Ghayoor G Ghasemi 2007 Association of the expression of IL-4 and IL-13 genes, IL-4 and IgE serum levels with allergic asthma Iran J Allergy Asthma Immunol 6 67 72 (Pubitemid 47203950)
33. WW Busse J Ring J Huss-Marp JE Kahn 2010 A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma J Allergy Clin Immunol 125 803 813 1:CAS:528:DC%2BC3cXktlGjurc%3D 20371394
34. F Ribeiro AJ Alves M Teixeira V Ribeiro JA Duarte J Oliveira 2009 Endothelial function and atherosclerosis: circulatory markers with clinical usefulness Rev Port Cardiol 28 1121 1151 20058778
35. E Lubos DE Handy J Loscalzo 2008 Role of oxidative stress and nitric oxide in atherothrombosis Front Biosci 13 5323 5344 1:CAS:528: DC%2BD1cXnsVOjtbg%3D 18508590
36. G Rodriguez N Mago F Rosa 2009 Role of inflammation in atherogenesis Invest Clin 50 109 129 19418732
37. P Puddu GM Puddu E Cravero S De Pascalis A Muscari 2009 The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis J Biomed Sci 16 112 20003216
38. E McNeill KM Channon DR Greaves 2010 Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications Clin Sci (Lond) 118 641 655 1:CAS:528:DC%2BC3cXivV2rs7w%3D
39. KJ Woollard F Geissmann 2010 Monocytes in atherosclerosis: subsets and functions Nat Rev Cardiol 7 77 86 20065951
40. A Sgambato A Cittadini 2010 Inflammation and cancer: a multifaceted link Eur Rev Med Pharmacol Sci 14 263 268 1:STN:280:DC%2BC3czlvVGmsA%3D%3D 20496533
41. SI Grivennikov FR Greten M Karin 2010 Immunity, inflammation, and cancer Cell 140 883 899 1:CAS:528:DC%2BC3cXlsVSgu7g%3D 20303878
42. A Mantovani 2010 Molecular pathways linking inflammation and cancer Curr Mol Med 10 369 373 1:CAS:528:DC%2BC3cXmsVamsb4%3D 20455855
43. CS Wang CF Sun 2009 C-reactive protein and malignancy: clinico-pathological association and therapeutic implication Chang Gung Med J 32 471 482 19840504
44. SE Erdman VP Rao W Olipitz CL Taylor EA Jackson T Levkovich CW Lee BH Horwitz JG Fox Z Ge T Poutahidis 2010 Unifying roles for regulatory T cells and inflammation in cancer Int J Cancer 126 1651 1665 1:CAS:528:DC%2BC3cXhtl2itL0%3D 19795459
45. A Federico F Morgillo C Tuccillo F Ciardiello C Loguercio 2007 Chronic inflammation and oxidative stress in human carcinogenesis Int J Cancer 121 2381 2386 1:CAS:528:DC%2BD2sXhtlShtb%2FN 17893868 (Pubitemid 350022406)
46. JL Kreindler 2010 Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies Pharmacol Ther 125 219 229 1:CAS:528:DC%2BC3cXitVKjsbY%3D 19903491
47. B Koller M Kappler P Latzin A Gaggar M Schreiner S Takyar M Kormann M Kabesch D Roos M Griese D Hartl 2008 TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease J Immunol 181 2753 2763 1:CAS:528: DC%2BD1cXptlOjs7k%3D 18684966
48. J Matricon 2010 Immunopathogenesis of inflammatory bowel disease Med Sci (Paris) 26 405 410
49. F Sanchez-Munoz A Dominguez-Lopez JK Yamamoto-Furusho 2008 Role of cytokines in inflammatory bowel disease World J Gastroenterol 14 4280 4288 1:CAS:528:DC%2BD1cXht1KrtbbF 18666314
50. J Wei J Feng 2010 Signaling pathways associated with inflammatory bowel disease Recent Pat Inflamm Allergy Drug Discov 4 105 117 1:CAS:528: DC%2BC3cXms1egs7g%3D 20001899
51. B Polinska J Matowicka-Karna H Kemona 2009 The cytokines in inflammatory bowel disease Postepy Hig Med Dosw (Online) 63 389 394
52. G Tonel C Conrad 2009 Interplay between keratinocytes and immune cells-recent insights into psoriasis pathogenesis Int J Biochem Cell Biol 41 963 968 1:CAS:528:DC%2BD1MXitVGjt74%3D 19027868
53. F Spah 2008 Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach Br J Dermatol 159 Suppl 2 10 17 18700910
54. J Mazza A Rossi JM Weinberg 2010 Innovative uses of tumor necrosis factor alpha inhibitors Dermatol Clin 28 559 575 1:CAS:528:DC%2BC3cXosFeru7c%3D 20510765
55. E Fitch E Harper I Skorcheva SE Kurtz A Blauvelt 2007 Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines Curr Rheumatol Rep 9 461 467 1:CAS:528:DC%2BD2sXhsVKgsL%2FE 18177599 (Pubitemid 350305203)
56. M Ishii Y Kurachi 2006 Muscarinic acetylcholine receptors Curr Pharm Des 12 3573 3581 1:CAS:528:DC%2BD28XhtFalsL7E 17073660 (Pubitemid 44509627)
57. C Gotti F Clementi A Fornari A Gaimarri S Guiducci I Manfredi M Moretti P Pedrazzi L Pucci M Zoli 2009 Structural and functional diversity of native brain neuronal nicotinic receptors Biochem Pharmacol 78 703 711 1:CAS:528:DC%2BD1MXhtVSmsLjK 19481063
58. G Sharma S Vijayaraghavan 2008 Nicotinic receptors containing the alpha7 subunit: a model for rational drug design Curr Med Chem 15 2921 2932 1:CAS:528:DC%2BD1cXhsVOjurjI 19075644
59. JX Shen JL Yakel 2009 Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system Acta Pharmacol Sin 30 673 680 1:CAS:528:DC%2BD1MXmvVSltL8%3D 19448647
60. SC Leiser MR Bowlby TA Comery J Dunlop 2009 A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits Pharmacol Ther 122 302 311 1:CAS:528:DC%2BD1MXmsVSgtbw%3D 19351547
61. WJ de Jonge L Ulloa 2007 The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation Br J Pharmacol 151 915 929 17502850 (Pubitemid 47195518)
62. K Kawashima T Fujii 2008 Basic and clinical aspects of non-neuronal acetylcholine: overview of non-neuronal cholinergic systems and their biological significance J Pharmacol Sci 106 167 173 1:CAS:528:DC%2BD1cXivFeit78%3D 18285657 (Pubitemid 351366333)
63. KJ Tracey 2007 Physiology and immunology of the cholinergic antiinflammatory pathway J Clin Invest 117 289 296 1:CAS:528: DC%2BD2sXhs1OqsLg%3D 17273548 (Pubitemid 46203953)
64. DW Wang RB Zhou YM Yao 2009 Role of cholinergic anti-inflammatory pathway in regulating host response and its interventional strategy for inflammatory diseases Chin J Traumatol 12 355 364 1:CAS:528:DC%2BC3cXitVSiurg%3D 19930906
65. DJ van Westerloo 2010 The vagal immune reflex: a blessing from above Wien Med Wochenschr 160 112 117 20364413
66. L Ulloa 2005 The vagus nerve and the nicotinic anti-inflammatory pathway Nat Rev Drug Discov 4 673 684 1:CAS:528:DC%2BD2MXmvVOqtr4%3D 16056392 (Pubitemid 41149761)
67. O Dowling B Rochelson K Way Y Al-Abed CN Metz 2007 Nicotine inhibits cytokine production by placenta cells via NFkappaB: potential role in pregnancy-induced hypertension Mol Med 13 576 583 1:CAS:528: DC%2BD1cXitVyguw%3D%3D 17878927 (Pubitemid 350228718)
68. RW Saeed S Varma T Peng-Nemeroff B Sherry D Balakhaneh J Huston KJ Tracey Y Al-Abed CN Metz 2005 Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation J Exp Med 201 1113 1123 1:CAS:528:DC%2BD2MXjtFWls70%3D 15809354 (Pubitemid 40524679)
69. RD Shytle T Mori K Townsend M Vendrame N Sun J Zeng J Ehrhart AA Silver PR Sanberg J Tan 2004 Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors J Neurochem 89 337 343 1:CAS:528:DC%2BD2cXjsFKksbw%3D 15056277 (Pubitemid 38495982)
70. JH Moon SY Kim HG Lee SU Kim YB Lee 2008 Activation of nicotinic acetylcholine receptor prevents the production of reactive oxygen species in fibrillar beta amyloid peptide (1-42)-stimulated microglia Exp Mol Med 40 11 18 1:CAS:528:DC%2BD1cXjtlGntr4%3D 18305393 (Pubitemid 351346812)
71. WR Parrish M Rosas-Ballina M Gallowitsch-Puerta M Ochani K Ochani LH Yang L Hudson X Lin N Patel SM Johnson S Chavan RS Goldstein CJ Czura EJ Miller Y Al-Abed KJ Tracey VA Pavlov 2008 Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling Mol Med 14 567 574 1:CAS:528:DC%2BD1cXht1ems7%2FP 18584048
72. M Rosas-Ballina KJ Tracey 2009 Cholinergic control of inflammation J Intern Med 265 663 679 1:CAS:528:DC%2BD1MXnslKrt74%3D 19493060
73. DJ van Westerloo IA Giebelen S Florquin MJ Bruno GJ Larosa L Ulloa KJ Tracey T van der Poll 2006 The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice Gastroenterology 130 1822 1830 16697744
74. DJ van Westerloo IA Giebelen S Florquin J Daalhuisen MJ Bruno AF de Vos KJ Tracey T van der Poll 2005 The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis J Infect Dis 191 2138 2148 15898001 (Pubitemid 40800586)
75. WJ de Jonge EP van der Zanden FO The MF Bijlsma DJ van Westerloo RJ Bennink HR Berthoud S Uematsu S Akira RM van den Wijngaard GE Boeckxstaens 2005 Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway Nat Immunol 6 844 851 16025117 (Pubitemid 43090471)
76. LC Gahring SW Rogers 2005 Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells AAPS J 7 E885 E894 1:CAS:528:DC%2BD28XhsVeit78%3D
77. BD Davies W Hoss JP Lin F Lionetti 1982 Evidence for a noncholinergic nicotine receptor on human phagocytic leukocytes Mol Cell Biochem 44 23 31 1:CAS:528:DyaL38XktlCmtbc%3D 7087960 (Pubitemid 12087076)
78. K Benhammou M Lee M Strook B Sullivan J Logel K Raschen C Gotti S Leonard 2000 [(3)H]Nicotine binding in peripheral blood cells of smokers is correlated with the number of cigarettes smoked per day Neuropharmacology 39 2818 2829 1:CAS:528:DC%2BD3cXntlGqtro%3D 11044752
79. MJ De Rosa L Dionisio E Agriello C Bouzat MC Esandi 2009 Alpha 7 nicotinic acetylcholine receptor modulates lymphocyte activation Life Sci 85 444 449 19632243
80. C Gotti F Clementi 2004 Neuronal nicotinic receptors: from structure to pathology Prog Neurobiol 74 363 396 1:CAS:528:DC%2BD2MXksVertA%3D%3D 15649582 (Pubitemid 40092737)
81. AI Chernyavsky J Arredondo M Skok SA Grando 2010 Auto/paracrine control of inflammatory cytokines by acetylcholine in macrophage-like U937 cells through nicotinic receptors Int Immunopharmacol 10 308 315 1:CAS:528: DC%2BC3cXis1Shsbw%3D 20004742
82. E Nizri M Irony-Tur-Sinai O Lory A Orr-Urtreger E Lavi T Brenner 2009 Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses J Immunol 183 6681 6688 1:CAS:528:DC%2BD1MXhtlKhtrzM 19846875
83. M Rosas-Ballina RS Goldstein M Gallowitsch-Puerta L Yang SI Valdes-Ferrer NB Patel S Chavan Y Al-Abed H Yang KJ Tracey 2009 The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE Mol Med 15 195 202 1:CAS:528:DC%2BD1MXotlajtL8%3D 19593403
84. K Rehani DA Scott D Renaud H Hamza LR Williams H Wang M Martin 2008 Cotinine-induced convergence of the cholinergic and PI3 kinase-dependent anti-inflammatory pathways in innate immune cells Biochim Biophys Acta 1783 375 382 1:CAS:528:DC%2BD1cXitVGksLc%3D 18178163
85. H Tilg AR Moschen 2008 Inflammatory mechanisms in the regulation of insulin resistance Mol Med 14 222 231 1:CAS:528:DC%2BD1cXksVensrk%3D 18235842 (Pubitemid 351481853)
86. M Zeyda TM Stulnig 2007 Adipose tissue macrophages Immunol Lett 112 61 67 1:CAS:528:DC%2BD2sXhtVertbnI 17719095 (Pubitemid 47379852)
87. JA Maasen 2008 Mitochondria, body fat and type 2 diabetes: what is the connection? Minerva Med 99 241 251 1:STN:280:DC%2BD1czjsVOrsg%3D%3D 18497722
88. H Ruan HF Lodish 2003 Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha Cytokine Growth Factor Rev 14 447 455 1:CAS:528:DC%2BD3sXms1Oqtr8%3D 12948526 (Pubitemid 37099456)
89. RH Liu M Mizuta S Matsukura 2004 The expression and functional role of nicotinic acetylcholine receptors in rat adipocytes J Pharmacol Exp Ther 310 52 58 1:CAS:528:DC%2BD2cXlsVOjsrs%3D 14993259 (Pubitemid 38812694)
90. D Carnevale R De Simone L Minghetti 2007 Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems CNS Neurol Disord Drug Targets 6 388 397 1:CAS:528:DC%2BD1cXitF2kurc%3D 18220778 (Pubitemid 351486253)
91. E Nizri M Irony-Tur-Sinai N Faranesh I Lavon E Lavi M Weinstock T Brenner 2008 Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine J Neuroimmunol 203 12 22 1:CAS:528:DC%2BD1cXhtFyls7fE 18692909
92. MV Guseva DM Hopkins SW Scheff JR Pauly 2008 Dietary choline supplementation improves behavioral, histological, and neurochemical outcomes in a rat model of traumatic brain injury J Neurotrauma 25 975 983 18665805
93. HJ Park PH Lee YW Ahn YJ Choi G Lee DY Lee ES Chung BK Jin 2007 Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action Eur J Neurosci 26 79 89 17581257 (Pubitemid 47035441)
94. T Suzuki I Hide A Matsubara C Hama K Harada K Miyano M Andra H Matsubayashi N Sakai S Kohsaka K Inoue Y Nakata 2006 Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role J Neurosci Res 83 1461 1470 1:CAS:528:DC%2BD28XmtlOqt74%3D 16652343 (Pubitemid 43844991)
95. MA van Maanen SP Stoof EP van der Zanden WJ de Jonge RA Janssen DF Fischer N Vandeghinste R Brys MJ Vervoordeldonk PP Tak 2009 The alpha7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients: a possible role for a key neurotransmitter in synovial inflammation Arthritis Rheum 60 1272 1281 19404936
96. JM Waldburger DL Boyle VA Pavlov KJ Tracey GS Firestein 2008 Acetylcholine regulation of synoviocyte cytokine expression by the alpha7 nicotinic receptor Arthritis Rheum 58 3439 3449 1:CAS:528:DC%2BD1cXhsV2hs7bN 18975306
97. Y Wang EF Pereira AD Maus NS Ostlie D Navaneetham S Lei EX Albuquerque BM Conti-Fine 2001 Human bronchial epithelial and endothelial cells express alpha7 nicotinic acetylcholine receptors Mol Pharmacol 60 1201 1209 1:CAS:528:DC%2BD3MXovVOitrY%3D 11723227 (Pubitemid 33144891)
98. MR Blanchet A Langlois E Israel-Assayag MJ Beaulieu C Ferland M Laviolette Y Cormier 2007 Modulation of eosinophil activation in vitro by a nicotinic receptor agonist J Leukoc Biol 81 1245 1251 1:CAS:528: DC%2BD2sXlsVWnurY%3D 17289799 (Pubitemid 46702043)
99. K Maouche M Polette T Jolly K Medjber I Cloez-Tayarani JP Changeux H Burlet C Terryn C Coraux JM Zahm P Birembaut JM Tournier 2009 Alpha7 nicotinic acetylcholine receptor regulates airway epithelium differentiation by controlling basal cell proliferation Am J Pathol 175 1868 1882 1:CAS:528:DC%2BC3cXhslSjt7g%3D 19808646
100. X Su MA Matthay AB Malik 2010 Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing Gram-negative sepsis-induced acute lung inflammatory injury J Immunol 184 401 410 1:CAS:528:DC%2BD1MXhsFOnsLbO 19949071
101. IA Giebelen DJ van Westerloo GJ Larosa AF de Vos T van der Poll 2007 Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung Shock 28 700 703 1:CAS:528:DC%2BD2sXhsVGitrvE 17621262 (Pubitemid 350135475)
102. B Xu A Makris C Thornton A Hennessy 2005 Glucocorticoids inhibit placental cytokines from cultured normal and preeclamptic placental explants Placenta 26 654 660 1:CAS:528:DC%2BD2MXns1Wgsbw%3D 16085044 (Pubitemid 41102687)
103. JY Kwon YH Kim SH Kim MH Kang YS Maeng KY Lee YW Park 2007 Difference in the expression of alpha 7 nicotinic receptors in the placenta in normal versus severe preeclampsia pregnancies Eur J Obstet Gynecol Reprod Biol 132 35 39 1:CAS:528:DC%2BD2sXkslWqtLc%3D 16837119
104. KS Lips D Bruggmann U Pfeil R Vollerthun SA Grando W Kummer 2005 Nicotinic acetylcholine receptors in rat and human placenta Placenta 26 735 746 1:CAS:528:DC%2BD2MXhtFSmsbrF 16226123 (Pubitemid 41535479)
105. H Kurzen I Wessler CJ Kirkpatrick K Kawashima SA Grando 2007 The non-neuronal cholinergic system of human skin Horm Metab Res 39 125 135 1:CAS:528:DC%2BD2sXltF2is7o%3D 17326008 (Pubitemid 46535570)
106. Y Moriwaki K Yoshikawa H Fukuda YX Fujii H Misawa K Kawashima 2007 Immune system expression of SLURP-1 and SLURP-2, two endogenous nicotinic acetylcholine receptor ligands Life Sci 80 2365 2368 1:CAS:528: DC%2BD2sXmtVehtb8%3D 17286989 (Pubitemid 46818253)
107. B Favre L Plantard L Aeschbach N Brakch S Christen-Zaech PA de Viragh A Sergeant M Huber D Hohl 2007 SLURP1 is a late marker of epidermal differentiation and is absent in Mal de Meleda J Invest Dermatol 127 301 308 1:CAS:528:DC%2BD2sXlt12isA%3D%3D 17008884 (Pubitemid 46106906)
108. F Chimienti RC Hogg L Plantard C Lehmann N Brakch J Fischer M Huber D Bertrand D Hohl 2003 Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda Hum Mol Genet 12 3017 3024 1:CAS:528:DC%2BD3sXovVWqtb4%3D 14506129 (Pubitemid 37442029)
109. M Bullo P Garcia-Lorda I Megias J Salas-Salvado 2003 Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression Obes Res 11 525 531 1:CAS:528:DC%2BD3sXjsVymt7c%3D 12690081 (Pubitemid 41202413)
110. P Dandona A Aljada A Bandyopadhyay 2004 Inflammation: the link between insulin resistance, obesity and diabetes Trends Immunol 25 4 7 1:CAS:528:DC%2BD3sXhtVSjtL7N 14698276 (Pubitemid 38032801)
111. MB Marrero R Lucas C Salet TA Hauser A Mazurov PM Lippiello M Bencherif 2010 An alpha7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes J Pharmacol Exp Ther 332 173 180 1:CAS:528:DC%2BC3cXis1yqtg%3D%3D 19786623
112. CR Gwilt LE Donnelly DF Rogers 2007 The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation? Pharmacol Ther 115 208 222 1:CAS:528:DC%2BD2sXns1yrsr0%3D 17597218 (Pubitemid 47042914)
113. A Linneberg NH Nielsen F Madsen L Frolund A Dirksen T Jorgensen 2001 Smoking and the development of allergic sensitization to aeroallergens in adults: a prospective population-based study. The Copenhagen Allergy Study Allergy 56 328 332 1:STN:280:DC%2BD3M3hslaqtQ%3D%3D 11284801 (Pubitemid 32222614)
114. LY Chen ZG Liu YH Li YZ Feng JR Wang 2008 Expression of neuronal acetylcholine receptor alpha 7 (nAChRalpha7) in peripheral blood CD(4)(+) T lymphocytes from asthmatic children Zhonghua Jie He He Hu Xi Za Zhi 31 803 805 19080531
115. NC Mishra J Rir-Sima-Ah RT Boyd SP Singh S Gundavarapu RJ Langley S Razani-Boroujerdi ML Sopori 2010 Nicotine inhibits fcφ RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through alpha7/alpha9/alpha10-nicotinic receptors J Immunol 185 588 596 1:CAS:528:DC%2BC3cXns1Cqtrw%3D 20505147
116. CM Greene H Ramsay RJ Wells SJ O'Neill NG McElvaney 2010 Inhibition of Toll-like receptor 2-mediated interleukin-8 production in cystic fibrosis airway epithelial cells via the alpha7-nicotinic acetylcholine receptor Mediators Inflamm 2010 423241 20379354
117. G Dorion E Israel-Assayag MJ Beaulieu Y Cormier 2005 Effect of 1, 1-dimethylphenyl 1,4-piperazinium on mouse tracheal smooth muscle responsiveness Am J Physiol Lung Cell Mol Physiol 288 L1139 L1145 1:STN:280: DC%2BD2M3ks1elsw%3D%3D 15695540
118. P Zhang D Han T Tang X Zhang K Dai 2008 Inhibition of the development of collagen-induced arthritis in Wistar rats through vagus nerve suspension: a 3-month observation Inflamm Res 57 322 328 1:CAS:528:DC%2BD1cXhtVSrsL%2FP 18607536
119. MA van Maanen MC Lebre T van der Poll GJ Larosa D Elbaum MJ Vervoordeldonk PP Tak 2009 Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice Arthritis Rheum 60 114 122 19116908
120. MA van Maanen SP Stoof GJ Larosa MJ Vervoordeldonk PP Tak 2010 Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice Ann Rheum Dis 69 1717 1723 20511609
121. YC Chung HW Ko E Bok ES Park SH Huh JH Nam BK Jin 2010 The role of neuroinflammation on the pathogenesis of Parkinson's disease BMB Rep 43 225 232 1:CAS:528:DC%2BC3cXmtlartr0%3D 20423606
122. T Nagatsu M Sawada 2005 Inflammatory process in Parkinson's disease: role for cytokines Curr Pharm Des 11 999 1016 1:CAS:528:DC%2BD2MXhvVChurk%3D 15777250 (Pubitemid 40331301)
123. Y Ouchi E Yoshikawa Y Sekine M Futatsubashi T Kanno T Ogusu T Torizuka 2005 Microglial activation and dopamine terminal loss in early Parkinson's disease Ann Neurol 57 168 175 1:CAS:528:DC%2BD2MXhs1Cisb8%3D 15668962 (Pubitemid 40179853)
124. LC Ajonuma PK Chan EH Ng KL Fok CH Wong LL Tsang XX Tang LS Ho MC Lau CM Chung Q He HY Huang DZ Yang DK Rowlands YW Chung HC Chan 2008 Involvement of cystic fibrosis transmembrane conductance regulator (CFTR) in the pathogenesis of hydrosalpinx induced by Chlamydia trachomatis infection J Obstet Gynaecol Res 34 923 930 1:CAS:528:DC%2BD1MXhtVGlsbw%3D 19012687
125. H Wilms L Zecca P Rosenstiel J Sievers G Deuschl R Lucius 2007 Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications Curr Pharm Des 13 1925 1928 1:CAS:528: DC%2BD2sXnsVWqsbs%3D 17584117 (Pubitemid 47017994)
126. L Zecca H Wilms S Geick JH Claasen LO Brandenburg C Holzknecht ML Panizza FA Zucca G Deuschl J Sievers R Lucius 2008 Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease Acta Neuropathol 116 47 55 1:CAS:528:DC%2BD1cXosVOjtLg%3D 18343932
127. M Quik K O'Leary CM Tanner 2008 Nicotine and Parkinson's disease: implications for therapy Mov Disord 23 1641 1652 18683238
128. M Westman M Engstrom AI Catrina J Lampa 2009 Cell specific synovial expression of nicotinic alpha 7 acetylcholine receptor in rheumatoid arthritis and psoriatic arthritis Scand J Immunol 70 136 140 1:CAS:528:DC%2BD1MXhtValsrjK 19630919
129. LV Borovikova S Ivanova M Zhang H Yang GI Botchkina LR Watkins H Wang N Abumrad JW Eaton KJ Tracey 2000 Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin Nature 405 458 462 1:CAS:528: DC%2BD3cXjslyltbY%3D 10839541 (Pubitemid 30367422)
130. H Wang MF Ward AE Sama 2009 Novel HMGB1-inhibiting therapeutic agents for experimental sepsis Shock 32 348 357 1:CAS:528:DC%2BD1MXpsVersbs%3D 19333143
131. L Ulloa KJ Tracey 2005 The "cytokine profile": a code for sepsis Trends Mol Med 11 56 63 1:CAS:528:DC%2BD2MXhtVGqs70%3D 15694867
132. H Wang H Liao M Ochani M Justiniani X Lin L Yang Y Al-Abed H Wang C Metz EJ Miller KJ Tracey L Ulloa 2004 Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis Nat Med 10 1216 1221 1:CAS:528:DC%2BD2cXptVOgtr8%3D 15502843 (Pubitemid 39540438)
133. JM Huston M Ochani M Rosas-Ballina H Liao K Ochani VA Pavlov M Gallowitsch-Puerta M Ashok CJ Czura B Foxwell KJ Tracey L Ulloa 2006 Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis J Exp Med 203 1623 1628 1:CAS:528:DC%2BD28XntVCgsr8%3D 16785311
134. X Wittebole S Hahm SM Coyle A Kumar SE Calvano SF Lowry 2007 Nicotine exposure alters in vivo human responses to endotoxin Clin Exp Immunol 147 28 34 1:CAS:528:DC%2BD2sXhtVCktLc%3D 17177960 (Pubitemid 44915552)
135. M Clodi G Vila R Geyeregger M Riedl TM Stulnig J Struck TA Luger A Luger 2008 Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men Am J Physiol Endocrinol Metab 295 E686 E691 1:CAS:528:DC%2BD1cXhtFCgt7zN 18593851
136. R Wu W Dong X Cui M Zhou HH Simms TS Ravikumar P Wang 2007 Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve Ann Surg 245 480 486 17435556 (Pubitemid 46673145)
137. S Hofer C Eisenbach IK Lukic L Schneider K Bode M Brueckmann S Mautner MN Wente J Encke J Werner AH Dalpke W Stremmel PP Nawroth E Martin PH Krammer A Bierhaus MA Weigand 2008 Pharmacologic cholinesterase inhibition improves survival in experimental sepsis Crit Care Med 36 404 408 1:CAS:528: DC%2BD1cXptlejsA%3D%3D 18091537 (Pubitemid 351158611)
138. JM Wolf BA Lashner 2002 Inflammatory bowel disease: sorting out the treatment options Cleve Clin J Med 69 621 631 12184470 (Pubitemid 34947057)
139. DA Scott M Martin 2006 Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases World J Gastroenterol 12 7451 7459 1:CAS:528:DC%2BD2sXhtFyrsL8%3D 17167832 (Pubitemid 46017741)
140. VE McGilligan JM Wallace PM Heavey DL Ridley IR Rowland 2007 Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis Inflamm Bowel Dis 13 108 115 17206646 (Pubitemid 46080016)
141. MC Aldhous RJ Prescott S Roberts K Samuel M Waterfall J Satsangi 2008 Does nicotine influence cytokine profile and subsequent cell cycling/apoptotic responses in inflammatory bowel disease? Inflamm Bowel Dis 14 1469 1482 18618634
142. JE Ghia P Blennerhassett H Kumar-Ondiveeran EF Verdu SM Collins 2006 The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model Gastroenterology 131 1122 1130 17030182 (Pubitemid 44498700)
143. JE Ghia P Blennerhassett SM Collins 2007 Vagus nerve integrity and experimental colitis Am J Physiol Gastrointest Liver Physiol 293 G560 G567 1:CAS:528:DC%2BD2sXhtVOqsbvM 17585014
144. PC Miceli K Jacobson 2003 Cholinergic pathways modulate experimental dinitrobenzene sulfonic acid colitis in rats Auton Neurosci 105 16 24 1:CAS:528:DC%2BD3sXjsVCjsLo%3D 12742187 (Pubitemid 36553064)
145. A Bai Y Guo N Lu 2007 The effect of the cholinergic anti-inflammatory pathway on experimental colitis Scand J Immunol 66 538 545 1:CAS:528: DC%2BD2sXhtlOhtb7J 17953529 (Pubitemid 47609702)
146. JE Ghia P Blennerhassett SM Collins 2008 Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression J Clin Invest 118 2209 2218 1:CAS:528:DC%2BD1cXntVCmurY%3D 18451995 (Pubitemid 351872339)
147. A Orr-Urtreger M Kedmi S Rosner F Karmeli D Rachmilewitz 2005 Increased severity of experimental colitis in alpha 5 nicotinic acetylcholine receptor subunit-deficient mice Neuroreport 16 1123 1127 1:CAS:528:DC%2BD2MXlsFajtro%3D 15973160 (Pubitemid 41017618)
148. S Shaw M Bencherif MB Marrero 2002 Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid J Biol Chem 277 44920 44924 1:CAS:528:DC%2BD38Xosl2mtrg%3D 12244045 (Pubitemid 36159088)
149. H Yoshikawa M Kurokawa N Ozaki K Nara K Atou E Takada H Kamochi N Suzuki 2006 Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7 Clin Exp Immunol 146 116 123 1:CAS:528:DC%2BD28XhtF2qsbnO 16968406 (Pubitemid 44393846)
150. T Spoettl C Paetzel H Herfarth M Bencherif J Schoelmerich R Greinwald GJ Gatto G Rogler 2007 (E)-metanicotine hemigalactarate (TC-2403-12) inhibits IL-8 production in cells of the inflamed mucosa Int J Colorectal Dis 22 303 312 16715250 (Pubitemid 46071108)
151. LC Gahring EL Days T Kaasch MM de Gonzalez L Owen K Persiyanov SW Rogers 2005 Pro-inflammatory cytokines modify neuronal nicotinic acetylcholine receptor assembly J Neuroimmunol 166 88 101 1:CAS:528:DC%2BD2MXntVCrurY%3D 16024094 (Pubitemid 41074660)
152. MV Skok R Grailhe F Agenes JP Changeux 2007 The role of nicotinic receptors in B-lymphocyte development and activation Life Sci 80 2334 2336 1:CAS:528:DC%2BD2sXmtVehtLs%3D 17363009 (Pubitemid 46818278)
153. SC Oloris AA Frazer-Abel CM Jubala SP Fosmire KM Helm SR Robinson DM Korpela MM Duckett S Baksh JF Modiano 2010 Nicotine-mediated signals modulate cell death and survival of T lymphocytes Toxicol Appl Pharmacol 242 299 309 1:CAS:528:DC%2BC3cXjt12gsg%3D%3D 19896492
154. S Nakao Y Ogata H Sugiya 2009 Nicotine stimulates the expression of cyclooxygenase-2 mRNA via NFkappaB activation in human gingival fibroblasts Arch Oral Biol 54 251 257 1:CAS:528:DC%2BD1MXhtlSltb0%3D 19147120
155. F Xiao J Zhu L Zhao G Zheng A Yang J Tao B Zhang Z Huang F Xiong 2010 Involvement of pro-inflammatory and anti-inflammatory cytokines in the anti-inflammatory activity of Rubus idaeus L. on LPS-treated RAW 264.7 cells J Chin Pharm Sci 19 201 208
156. M Martinez-Ferrer JM Iturregui C Uwamariya J Starkman AR Sharif-Afshar K Suzuki W Visedsindh RJ Matusik RR Dmochowski NA Bhowmick 2008 Role of nicotinic and estrogen signaling during experimental acute and chronic bladder inflammation Am J Pathol 172 59 67 1:CAS:528:DC%2BD1cXhslOmtLk%3D 18079438 (Pubitemid 351186368)
157. N Sawe G Steinberg H Zhao 2008 Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke J Neurosci Res 86 1659 1669 1:CAS:528: DC%2BD1cXnt1ektLc%3D 18189318 (Pubitemid 351859418)